CAMP4 Therapeutics Corporation logo

CAMP4 Therapeutics Corporation

CAMP | NASDAQ
Chart Builder DCF Calculator
$4.18
+$0.01 (+0.24%)
Sep 22, 2026, 2:05 PM ET · Market open

Market Data

Market Cap
$88.57M
Enterprise Value
$4.55M
Beta
0.21
Average Volume
217.99K
Shares Outstanding (Diluted)
57.93M
Shares Change YoY
187.35%
Institutional Ownership
68.68%
Exchange
NASDAQ
ISIN
US13463J1016

Price Performance

Price Change 1M
-5.2%
Price Change 3M
-4.4%
Price Change 6M
-12.2%
Price Change YTD
-30.5%
Price Change 1Y
51.6%
Price Change 3Y
-61.1%
Price Change 5Y
-61.1%
1M CAGR (ann.)
-1.6%
1Y CAGR (ann.)
66.8%
5Y CAGR (ann.)
N/A
All-Time CAGR
-38.5%

Valuation

PE Ratio
-1.87
Forward PE
N/A
PEG Ratio
-0.12
Forward PEG
0.06
PS Ratio
21.01
Forward PS
17.00
PB Ratio
-127.81
P/FCF Ratio
-3.08
P/Adj. FCF Ratio
-2.59
P/OCF Ratio
-8.51
EV/Sales
1.08
EV/EBIT
-0.06
EV/EBITDA
-0.06
EV/FCF
-0.16
Earnings Yield
-53.5%
FCF Yield
-32.4%
Adj. FCF Yield
-38.7%

Financial Health

Net Cash
$84.03M
Total Debt
$2.37M
Cash & Short-Term Investments
$86.4M
Total Assets
$93.43M
Current Ratio
4.70
Quick Ratio
4.70
Debt / Equity Ratio
-3.42
Debt / EBITDA
-0.03
Debt / FCF
-0.08
OCF / Debt
-12.05
Interest Coverage
0.00
Altman Z-Score
-6.27
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
77.8%
Operating Profit Margin
-1242.5%
EBITDA Margin
-1735.5%
Net Profit Margin
-2543.7%
FCF Margin
-681.2%
Adj. FCF Margin
-812.6%
SBC / Revenue
131.4%
SBC Impact (per share)
-19.3%

Returns

Return on Assets
-114.8%
Return on Equity
-314.1%
Return on Invested Capital
-69.8%
Return on Capital Employed
-70.5%
Return on Tangible Assets
-114.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
-75.9%
Revenue CAGR 5Y
-58.3%
Revenue CAGR 10Y
-34.9%
EPS CAGR 3Y
32.8%
EPS CAGR 5Y
-19.8%
EPS CAGR 10Y
-24.7%
FCF CAGR 3Y
18.8%
FCF CAGR 5Y
-5.9%
FCF CAGR 10Y
-167.5%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
24
EPS Growth Next 3Y
22.3%
Revenue Growth Next 3Y
-25.8%
Earnings Date
Aug 12, 2026
EPS Estimate (next Q)
-$0.21
EPS Growth Est (next Q)
-65.9%
Revenue Est (next Q)
$1.62M
Revenue Growth Est (next Q)
8.2%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$10.75
Price Target Upside
157.8%

Cash Flow

Operating Cash Flow
$-28.59M
Free Cash Flow
$-28.72M
Adj. Free Cash Flow
$-34.26M
FCF Per Share
-$0.50
OCF Per Share
-$0.49
OCF/S Ratio
-678.2%

Income Statement

Revenue
$4.22M
Gross Profit
$3.28M
Operating Income
$-52.38M
EBITDA
$-73.17M
Net Income
$-107.24M
EPS (Diluted)
-$2.23
Revenue / Employee
$87.83K
Profit / Employee
$-2.23M
Employees
48

© 2026 bestshares.com. All rights reserved.